Full Text | PDF

Share on tweeters Share on facebook Share on linkedin Share on googleplus

J Cancer 2017; 8(14):2828-2835. doi:10.7150/jca.19524 This issue Cite

Research Paper

Prognostic Impact of ABO Blood Group on Type I Endometrial Cancer Patients- Results from Our Own and Other Studies

Vincenzo Dario Mandato1*✉, Federica Torricelli2*, Valentina Mastrofilippo3, Gino Ciarlini3, Debora Pirillo1, Enrico Farnetti4, Loretta Fornaciari4, Bruno Casali4, Maria Carolina Gelli5, Martino Abrate3, Lorenzo Aguzzoli3, Giovanni Battista La Sala1,6#, Davide Nicoli4#

1. Unit of Obstetrics and Gynaecology, Azienda Unità Sanitaria Locale - Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS), Reggio Emilia, Italy;
2. Laboratory of Translational Research, Azienda Unità Sanitaria Locale-Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS), Reggio Emilia, Italy;
3. Unit of Surgical Gynecol Oncology, Azienda Unità Sanitaria Locale - Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS), Reggio Emilia, Italy;
4. Laboratory of Molecular Biology, Azienda Unità Sanitaria Locale - Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS), Reggio Emilia, Italy;
5. Unit of Pathology, Azienda Unità Sanitaria Locale - Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS), Reggio Emilia, Italy;
6. Unit of Obstetrics and Gynaecology, University of Modena and Reggio Emilia, Reggio Emilia, Italy.
* These two authors contributed equally
# These two authors contributed equally

✉ Corresponding author: Vincenzo Dario Mandato, Unit of Obstetrics and Gynecology, Azienda Unità Sanitaria Locale, IRCCS, Viale Risorgimento 80, 42123 Reggio Emilia (Italy). Tel: +39 3494640813, Fax: +39 0522296015, e-mail: dariomandatocom More

Citation:
Mandato VD, Torricelli F, Mastrofilippo V, Ciarlini G, Pirillo D, Farnetti E, Fornaciari L, Casali B, Gelli MC, Abrate M, Aguzzoli L, La Sala GB, Nicoli D. Prognostic Impact of ABO Blood Group on Type I Endometrial Cancer Patients- Results from Our Own and Other Studies. J Cancer 2017; 8(14):2828-2835. doi:10.7150/jca.19524. https://www.jcancer.org/v08p2828.htm
Other styles

File import instruction

Abstract

Objectives: The ABO blood group antigens were found on most epithelial cells and in secretions. In the normal endometrium there is a variable expression of histo-blood group and related antigens suggesting a hormonal regulation. A relationship between ABO blood groups and endometrial cancer has been investigated with contradictory results. In this study we investigated the influence of blood types on clinical and pathological characteristics of endometrial cancer patients.

Method: Retrospective cohort study. Clinical and pathological data were extrapolated and their association with blood groups were assessed.

Results: A total of 203 type I endometrial cancer patients were included in the final analysis. Univariate analysis indicated that a lower frequency of G3 undifferentiated tumors was observed in patients with A blood group (P=0.027). Multivariate analysis, including also clinical features such as Age, BMI, parity, hypertension and diabetes confirmed that patients with A group present a lower risk of G3 tumors in comparison with not A patients. (OR=0.32, P=0.011).

Conclusions: Patients with A genotype have a lower risk to develop G3 type I endometrial cancer. ABO blood group might represent a useful, easy access and cheap biomarker for patients' selection and for management personalization of endometrial cancer patients.

Keywords: Endometrial cancer, Type I endometrial cancer, ABO blood group, Grading, A blood group.

Citation styles

APA
Mandato, V.D., Torricelli, F., Mastrofilippo, V., Ciarlini, G., Pirillo, D., Farnetti, E., Fornaciari, L., Casali, B., Gelli, M.C., Abrate, M., Aguzzoli, L., La Sala, G.B., Nicoli, D. (2017). Prognostic Impact of ABO Blood Group on Type I Endometrial Cancer Patients- Results from Our Own and Other Studies. Journal of Cancer, 8(14), 2828-2835. https://doi.org/10.7150/jca.19524.

ACS
Mandato, V.D.; Torricelli, F.; Mastrofilippo, V.; Ciarlini, G.; Pirillo, D.; Farnetti, E.; Fornaciari, L.; Casali, B.; Gelli, M.C.; Abrate, M.; Aguzzoli, L.; La Sala, G.B.; Nicoli, D. Prognostic Impact of ABO Blood Group on Type I Endometrial Cancer Patients- Results from Our Own and Other Studies. J. Cancer 2017, 8 (14), 2828-2835. DOI: 10.7150/jca.19524.

NLM
Mandato VD, Torricelli F, Mastrofilippo V, Ciarlini G, Pirillo D, Farnetti E, Fornaciari L, Casali B, Gelli MC, Abrate M, Aguzzoli L, La Sala GB, Nicoli D. Prognostic Impact of ABO Blood Group on Type I Endometrial Cancer Patients- Results from Our Own and Other Studies. J Cancer 2017; 8(14):2828-2835. doi:10.7150/jca.19524. https://www.jcancer.org/v08p2828.htm

CSE
Mandato VD, Torricelli F, Mastrofilippo V, Ciarlini G, Pirillo D, Farnetti E, Fornaciari L, Casali B, Gelli MC, Abrate M, Aguzzoli L, La Sala GB, Nicoli D. 2017. Prognostic Impact of ABO Blood Group on Type I Endometrial Cancer Patients- Results from Our Own and Other Studies. J Cancer. 8(14):2828-2835.

This is an open access article distributed under the terms of the Creative Commons Attribution (CC BY-NC) license (https://creativecommons.org/licenses/by-nc/4.0/). See http://ivyspring.com/terms for full terms and conditions.
Popup Image

©2024 Ivyspring International Publisher. Terms of use